Terms: = Lung cancer AND TSC2, FLJ43106, 7249, ENSG00000103197, LAM, tuberin, TSC4 AND Prognosis
40 results:
1. Sporadic Lymphangioleiomyomatosis Disease: A Case Report.
Nikmanesh Y; Shokripour M; Mokhtari M; Khazayi M; Monabati A; Rezayi R; Bahtouee M
Iran J Med Sci; 2023 Sep; 48(5):516-521. PubMed ID: 37786468
[TBL] [Abstract] [Full Text] [Related]
2. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Retroperitoneal Lymphangioleiomyomatosis].
Kambe T; Yamasaki T; Nagoshi A; Fujiwara T; Mine Y; Hagimoto H; Hattori Y; Abe Y; Yamashita D; Tsutsumi N; Kawakita M
Hinyokika Kiyo; 2023 Jun; 69(6):151-155. PubMed ID: 37460278
[TBL] [Abstract] [Full Text] [Related]
4. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
5. HDAC6-G3BP2 promotes lysosomal-tsc2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer.
Liu B; Zhang J; Meng X; Xie SM; Liu F; Chen H; Yao D; Li M; Guo M; Shen H; Zhang X; Xing L
Oncogene; 2023 Apr; 42(15):1181-1195. PubMed ID: 36823378
[TBL] [Abstract] [Full Text] [Related]
6. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.
Zhang H; Hu Z; Wang S; Wu K; Yang Q; Song X
Medicine (Baltimore); 2022 Dec; 101(52):e32492. PubMed ID: 36596036
[TBL] [Abstract] [Full Text] [Related]
7. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
Touraine R; Hauet Q; Harzallah I; Baruteau AE
Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
[TBL] [Abstract] [Full Text] [Related]
8. Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis.
Yoon HY; Kim HJ; Song JW
Respir Res; 2022 Jun; 23(1):158. PubMed ID: 35717210
[TBL] [Abstract] [Full Text] [Related]
9. [Pulmonary lymphangioleiomyomatosis (lam)].
Theegarten D; Hager T
Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
[TBL] [Abstract] [Full Text] [Related]
10. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
[TBL] [Abstract] [Full Text] [Related]
11. Lymphangioleiomyomatosis.
Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
[TBL] [Abstract] [Full Text] [Related]
12. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
Treichel AM; Hamieh L; Nathan NR; Tyburczy ME; Wang JA; Oyerinde O; Raiciulescu S; Julien-Williams P; Jones AM; Gopalakrishnan V; Moss J; Kwiatkowski DJ; Darling TN
Genet Med; 2019 Nov; 21(11):2594-2604. PubMed ID: 31114024
[TBL] [Abstract] [Full Text] [Related]
13. Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas.
Liang X; Li Q; Xu B; Hu S; Wang Q; Li Y; Zong Y; Zhang S; Li C
Int J Clin Oncol; 2019 Sep; 24(9):1061-1068. PubMed ID: 31065835
[TBL] [Abstract] [Full Text] [Related]
14. tsc2 genetic variant and prognosis in non-small cell lung cancer after curative surgery.
Lee YH; Do SK; Lee SY; Kang HG; Choi JE; Hong MJ; Lee JH; Lee EB; Jeong JY; Shin KM; Lee WK; Seok Y; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Jheon S; Park JY
Thorac Cancer; 2019 Feb; 10(2):335-340. PubMed ID: 30585697
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract] [Full Text] [Related]
16. [Sporadic Lymphangioleiomyomatosis (slam) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations].
Brakemeier S; Grohé C; Bachmann F; Budde K
Pneumologie; 2017 Feb; 71(2):86-95. PubMed ID: 27585353
[TBL] [Abstract] [Full Text] [Related]
17. lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract] [Full Text] [Related]
18. [A case of incidentally diagnosed retroperitoneal lymphangioleiomyomatosis with no respiratory symptoms].
Tanaka K; Miyazaki J; Uchida M; Ichioka D; Kimura T; Oikawa T; Suetomi T; Kawai K; Uesugi N; Nasu K; Nishiyama H
Hinyokika Kiyo; 2013 Nov; 59(11):709-13. PubMed ID: 24322407
[TBL] [Abstract] [Full Text] [Related]
19. [Lymphangioleiomyomatosis].
Wirtz H
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S59-74; quiz 75-6. PubMed ID: 24277558
[TBL] [Abstract] [Full Text] [Related]
20. Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis.
Bujalance-Cabrera C; Vaquero-Barrios JM; Redel-Montero J; Caballero-Ballesteros L; Requejo-Jiménez A; Santos-Luna F
Arch Bronconeumol; 2012 Dec; 48(12):479-81. PubMed ID: 22444789
[TBL] [Abstract] [Full Text] [Related]
[Next]